CI
EXEL icon

Cordant Inc’s Exelixis EXEL Stock Holding History

Cordant Inc’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-95
Closed -$2K – 456
2022
Q1 		$2K Buy
+95
New +$1.86K ﹤0.01% 636

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cordant Inc's EXEL Position: Q2 2022 in Review

Cordant Inc sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 95 shares — an estimated $2K sold.

Cordant Inc first reported a position in EXEL in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 373 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

  • Cordant Inc reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
  • Cordant Inc sold 95 Exelixis shares in Q2 2022, an estimated $2K.
  • Cordant Inc first reported a position in Exelixis in Q1 2022 and held it in 1 quarter.
  • Cordant Inc's Exelixis position peaked at $2K in Q1 2022.
  • 373 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.